Asset Management One Co., Ltd. United Therapeutics Corp Transaction History

Asset Management One Co., Ltd.

$31.2 Billion
Q2 2025

A detailed history of Asset Management One Co., Ltd. transactions in United Therapeutics Corp stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 25,051 shares of UTHR stock, worth $7.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

25,051

Previous 25,873 3.18%

Holding current value

$7.55 Million

Previous $7.98 Million 9.74%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$276.47 - $328.4 $227,258 - $269,944	-822 Reduced 3.18%	25,051 $7.2 Million
Q1 2025 Apr 23, 2025	SELL	$304.42 - $380.78 $73,365 - $91,767	-241 Reduced 0.92%	25,873 $7.98 Million
Q4 2024 Jan 30, 2025	SELL	$348.66 - $410.0 $211,985 - $249,280	-608 Reduced 2.28%	26,114 $9.21 Million
Q3 2024 Oct 30, 2024	SELL	$311.04 - $363.55 $5,909 - $6,907	-19 Reduced 0.07%	26,722 $9.58 Million
Q2 2024 Jul 18, 2024	BUY	$228.26 - $319.04 $1.52 Million - $2.13 Million	6,663 Added 33.19%	26,741 $8.52 Million
Q1 2024 May 02, 2024	SELL	$210.76 - $249.51 $718,902 - $851,078	-3,411 Reduced 14.52%	20,078 $4.61 Million
Q4 2023 Jan 24, 2024	BUY	$214.88 - $256.94 $111,952 - $133,865	521 Added 2.27%	23,489 $5.16 Million
Q3 2023 Oct 19, 2023	BUY	$211.82 - $248.24 $134,082 - $157,135	633 Added 2.83%	22,968 $5.19 Million
Q2 2023 Jul 31, 2023	BUY	$205.19 - $232.99 $697,030 - $791,467	3,397 Added 17.94%	22,335 $4.93 Million
Q1 2023 Apr 25, 2023	BUY	$212.99 - $276.17 $4.03 Million - $5.23 Million	18,938 New	18,938 $4.24 Million
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $1.79 Million - $2.84 Million	-23,533 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $5.62 Million - $6.65 Million	-52,422 Reduced 69.02%	23,533 $2.76 Million
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $166,803 - $211,760	-1,645 Reduced 2.12%	75,955 $8.23 Million
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $61,912 - $70,426	-544 Reduced 0.7%	77,600 $9.9 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $165,363 - $193,436	1,635 Added 2.14%	78,144 $8.82 Million
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $94,130 - $133,403	878 Added 1.16%	76,509 $8.6 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $836,819 - $1.07 Million	-7,057 Reduced 8.53%	75,631 $11.2 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $1.81 Million - $2.16 Million	15,805 Added 23.63%	82,688 $9.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	66,883	66,883 $8.68 Million

Others Institutions Holding UTHR

# of Institutions

730

Shares Held

43.3M

Call Options Held

125K

Put Options Held

124K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. United Therapeutics Corp Transaction History